Americans for Safe Access

APRIL 2, 2019

The Americans for Safe Access 2019 Unity Conference, themed The Price of Being a Medical Cannabis Patient, featured over a hundred patients from all over America visiting their representatives in Congress and the Senate to promote the Medical Cannabis Control Act of 2019. Which agency will have authority over medical cannabis policy?

Access

United Patients Group

JANUARY 15, 2023

However, the DEA and FDA still consider CBD a drug regulated under the Schedule I classification. The DEA definition of a Schedule 1 substance is : Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Book a consultation today.

THC

Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA

The Blunt Truth

APRIL 2, 2020

DEA GUIDANCE. Scientists at the Scottsdale Research Institute have filed suit against the agency, claiming that the DEA has changed its interpretation of federal statutes and treaty obligations, without detailing how it arrived at its new view of the law. So now Idaho stands alone as the only state where no form of cannabis is legal.

DEA

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis. DEA finally relents.

DEA

The Cannigma

MAY 16, 2025

The successes of cannabis businesses are now a part of the mainstream conversation and considered big business, while the rights and protections for medical cannabis patients have been sidelined. So while a cannabis business can join their local chamber of commerce, a patient in hospice can be denied access to medical cannabis.

Policy

Canna Law Blog

MARCH 4, 2020

According to the FDA , “once the FDA approves a drug, healthcare providers generally may prescribe the drug for an unapproved use when they judge that it is medically appropriate for their patient.” Failure to follow these very specific legal directives can lead to immediate criminal liability under federal law.

Therapy

Cannabis Law Report

OCTOBER 4, 2021

One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression. Adult Oregonians will be able to access psilocybin therapy under the PSA beginning in January 2023; patients with advanced illness are among those who may benefit from this therapy.

Therapy

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.

DEA

NORML

APRIL 30, 2024

“It is significant for these federal agencies, and the DEA and FDA in particular, to acknowledge publicly for the first time what many patients and advocates have known for decades: that cannabis is a safe and effective therapeutic agent for tens of millions of Americans.”

DEA

MedicalJane

MAY 14, 2020

It continues to enforce restrictive policies and regulations on research into the health benefits or harms of cannabis products that are available to consumers across the nation. Because of this, some cannabis companies are even investing money into facilitating their own private studies to get a better understanding of what patients need.

Sleep

Veriheal

DECEMBER 11, 2020

Further, the DEA hasn’t exactly been helping matters, in fact, they may even be making things worse. . The DEA has thwarted research by refusing to process and approve any additional cannabis manufacturers. The agency has undergone several lawsuits filed by scientists, activists, and patients over the matter. .

DEA

Veriheal

SEPTEMBER 13, 2022

With legalization, patients and consumers have more freedom in product choice, and many are turning to homegrown cannabis. The change he pointed out was in how the DEA treats marijuana seeds. Cultivation Costs for Homegrowers.

Cultivation

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. POPLAR will publish original law and policy research. CR: Can you describe the existing landscape of psychedelics research?

Law

Veriheal

NOVEMBER 6, 2023

Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. The Act aimed to provide patients access to smokable flower for 15 medical conditions. This progressive legislation, once implemented, means a brand new slew of patients will have access to cannabis medicine.

Legalization

SpeedWeed

MARCH 28, 2021

That’s what most providers are worried about when their patients with PTSD decide to try cannabis.”. As a result, there has been more interest among patients, clinicians, and researchers to see if cannabis is effective in treating PTSD. . Many veterans with PTSD already use cannabis to self-treat their symptoms.

Clinical Trials

The Cannigma

DECEMBER 13, 2021

As a matter of fact, the Korean DEA (Drug Enforcement Agency) has been known to enter clubs and perform random drug searches. . Today, however, due to draconian government policies, the use of weed is extremely taboo. Drug pickup is available from Seoul only – no matter where in South Korea the patient resides.

Legalization

Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. According to the DEA order, because the drug was recently approved by the FDA, it is now considered to have an accepted medical use.

CBD

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Authors Tracy Gallegos and Neville M.

Business

Veriheal

OCTOBER 23, 2020

Congresswoman Alexandria Ocasio-Cortez, or also known as AOC, pointed out that both sides are coming together on issues concerning civil rights, policy and bringing an end to old drug prohibition laws. . House Republicans supported her proposal to defund the DEA and divert those funds to opioid treatment programs. .

DEA

Veriheal

OCTOBER 23, 2020

Congresswoman Alexandria Ocasio-Cortez, or also known as AOC, pointed out that both sides are coming together on issues concerning civil rights, policy and bringing an end to old drug prohibition laws. . House Republicans supported her proposal to defund the DEA and divert those funds to opioid treatment programs. .

DEA

United Patients Group

FEBRUARY 21, 2023

On a federal level, CBD is still classified as a Schedule I drug by the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA). The post Understanding the 4 Major Differences Between CBD and THC appeared first on United Patients Group. Legality In the United States, cannabis laws are changing rapidly.

THC

Veriheal

AUGUST 19, 2022

But times are changing, and leaders are now calling for revamped policies on psilocybin, hemp, and cannabis research for varying reasons. In February 2021, a lawsuit was filed against the DEA for prohibiting access for others aside from the University of Mississippi to cultivate cannabis for research purposes.

Hemp

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy

Sensi Seeds

NOVEMBER 28, 2018

Irrespective of where the directive came from, policy on CBD has changed. Some companies who were reportedly affected by the policy update include Gea Seeds, Grow Barato, and HortiTec who received a letter from AECOSAN, and were subsequently raided. CBD Regulation is Needed.

CBD

Cannabis Law Report

JANUARY 13, 2022

In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. McGuireWoods LLP. Newsworthy Highlights. Happy 2022! Montana: As of Jan. Louisiana: As of Jan.

Dispensary

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. MAPS hired Sylvia Thyssen as our first employee , celebrated the 50th anniversary of LSD , outlined perspectives on drug policy , and worked toward facilitating a pilot study for medical marijuana. Lyle Craker, Ph.D., Source: [link].

Clinical Trials

Cannabis Law Report

MAY 24, 2022

Defendant and respondent Oakland Cannabis Buyers’ Cooperative created a medical dispensary that would serve eligible patients. The criminalization of marijuana was the result of racially motivated policies, such as the Marijuana Tax Act of 1937. The Tax Act was litigated in Leary v.

DEA

Marijuana Packaging

SEPTEMBER 23, 2024

Over the years they have even attempted to shut down the pages of medical marijuana stores that were using their pages to communicate to patients, allowing them to keep up to date on strain availability and other information pertaining to treating specific conditions. It is also legal for medicinal purposes in 29 states.

DEA

SpeedWeed

APRIL 1, 2021

Her pro-pot policies would take shape in college during the ’90s and early 2000s. Fried remembers the debate, featuring a then- High Times editor and a DEA agent, marking the first substantive cannabis conversation during her time at school. . In time, she would help bring a national great debates series to campus.

Agriculture

Cannabis Law Report

JUNE 9, 2021

If you’re moving within one of those states and are discovered to have any weed on your person, you’ll be asked to present your medical marijuana patient card. You could still find yourself dealing with Big Daddy DEA, even with a medical marijuana card at the ready, and even if you’re still within the state that issued it.

Marijuana

Cannabis Law Report

JULY 30, 2019

The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . In light of all this state cannabis information overload, what are some of the reasons a patient ultimately chooses a qualified personal cannabis physician? .

Marijuana

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Executive Summary. Marijuana Possession for Personal Use.

Cannabinoids

Cannabis Law Report

JULY 14, 2021

Legislation opens doors for cannabis policy reform in the current Congress. Cory Booker (D-NJ) and Ron Wyden (D-OR), released draft legislation today that would remove cannabis from the schedule of controlled substances while allowing states to determine their own cannabis policies. WASHINGTON, D.C. Senators Cory Booker, D-N.J.,

Legislation

The Joint Blog

MARCH 4, 2021

These symptoms mainly had to do with digestion, easing nausea, vomiting, and stomach pain that patients experienced. This is partly due to the heavy involvement of the DEA throughout the production process. The biggest change to come out of the recent change was the improved negligence violation policy.

Legislation

Cannabis Law Report

AUGUST 16, 2019

Immediately, regulators in other states with newly legalized programs will seek to avoid similar pitfalls while striking an effective regulatory balance: Oregon’s unlimited license policy is an opposite example of what other states yet prefer to avoid. Florida’s marijuana future is showing promise.

Marijuana